ARATANA THERAPEUTICS, INC. - FORM 10-K - EX-23.1 - March 14, 2018

Attached files

file filename
EX-32.2 - EX-32.2 - ARATANA THERAPEUTICS, INC.petx-20171231xex32_2.htm
EX-32.1 - EX-32.1 - ARATANA THERAPEUTICS, INC.petx-20171231xex32_1.htm
EX-31.2 - EX-31.2 - ARATANA THERAPEUTICS, INC.petx-20171231xex31_2.htm
EX-31.1 - EX-31.1 - ARATANA THERAPEUTICS, INC.petx-20171231xex31_1.htm
EX-21.1 - EX-21.1 - ARATANA THERAPEUTICS, INC.petx-20171231xex21_1.htm
10-K - 10-K - ARATANA THERAPEUTICS, INC.petx-20171231x10k.htm

Exhibit 23.1







CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (Nos. 333-189687, 333-193472, 333-203003, 333-210232 and 333-216682) and Form S-3 (No. 333-219681) of Aratana Therapeutics, Inc. of our report dated March 14, 2018 relating to the financial statements, which appears in this Form 10‑K. 

/s/ PricewaterhouseCoopers LLP



Boston, Massachusetts



March 14, 2018



ARATANA THERAPEUTICS, INC. Reports